Referral of intravenous drug users for antiviral treatment: effectiveness of hepatitis C case-finding programmes
Language English Country Czech Republic Media print
Document type Journal Article, Research Support, Non-U.S. Gov't
PubMed
23285525
DOI
10.21101/cejph.a3747
Knihovny.cz E-resources
- MeSH
- Antiviral Agents therapeutic use MeSH
- Hepatitis C diagnosis epidemiology therapy MeSH
- Substance Abuse, Intravenous epidemiology therapy MeSH
- Referral and Consultation statistics & numerical data MeSH
- Humans MeSH
- Patient Acceptance of Health Care statistics & numerical data MeSH
- Mass Screening statistics & numerical data MeSH
- Health Behavior MeSH
- Health Services statistics & numerical data MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Geographicals
- Hungary epidemiology MeSH
- Names of Substances
- Antiviral Agents MeSH
BACKGROUND: Hepatitis C infection (HCI) case-finding programmes aim to identify infected persons in a well-defined population. This study assessed the effectiveness of three HCI case-finding programmes for intravenous drug users by examining the rate of their referral to antiviral treatment. METHODS: The Hepatology Outpatient Clinic of Szent László Hospital examines and treats all intravenous drug users who are found positive in HCI case-finding programmes in Budapest. The medical records of patients who visited the Hepatology Outpatient Clinic of Szent László Hospital between 1 January 2006 and 31 December 2008 were screened and records indicating a history of drug abuse were selected. These records were matched against the databases of the hepatitis case-finding programmes and the records that appeared in both datasets were analyzed. RESULTS: Of the 234 intravenous drug users identified as hepatitis C virus positive in the Budapest case-finding programmes, only 21 attended the Hepatology Outpatient Clinic of Szent László Hospital and only two started antiviral treatment, but their hepatitis C virus positive status had already been known at the time of screening. CONCLUSION: In this study, not a single patient with drug abuse whose hepatitis C virus positive status was identified in one of the HCI case-finding programmes was referred for antiviral treatment.
References provided by Crossref.org